Inventor · disambiguated record
Ian Davis
Also filed as: DAVIS IAN · DAVIS IAN C · DAVIS IAN CHRISTOPHER
4 granted patents·14 pending applications·3 citations·filing 2004–2024
62Inventor score
Files withOHIO STATE INNOVATION FOUNDATION6XEROX CORP3CEBON JONATHAN1CSL LTD1CSL LTD LUDWIG INST FOR CANCER1
Top patents by PatentIndex Score
18 records- 0176US10874684B2Liponucleotide-based therapy for ARDSOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Dec 29, 2020·1 cites·36 claims
- 0268US11154621B2Liponucleotide-based therapy for COPDOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Oct 26, 2021·1 cites·9 claims
- 0362US8420791B2Expression of FoxP3 by cancer cellsEBERT LISA MICHELLE·Filed 2007·Granted Apr 16, 2013·1 cites·5 claims
- 0462US2025103013A1Multi-variant control system for an industrial facilityX ENERGY LLC·Filed 2024·Application pending·0 cites
- 0560US2025170246A1Cdp-choline a host-directed therapeutic for disease caused by sars cov-2 infectionOHIO STATE INNOVATION FOUNDATION·Filed 2023·Application pending·0 cites
- 0658US2022062425A1Liponucleotide-based therapy for copdOHIO STATE INNOVATION FOUNDATION·Filed 2021·Application pending·0 cites
- 0755US2021069225A1Liponucleotide-based therapy for ardsOHIO STATE INNOVATION FOUNDATION·Filed 2020·Application pending·0 cites
- 0848US11850283B2Liponucleotide-based therapy for asthmaOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Dec 26, 2023·0 cites·15 claims
- 0947US2007190072A1In vivo efficacy of ny-eso-1 plus adjuvantCSL LTD LUDWIG INST FOR CANCER·Filed 2004·Application pending·0 cites
- 1047US2025254248A1Multi-function device (mfd) systemXEROX CORP·Filed 2024·Application pending·0 cites
- 1147US2025254245A1Multi-function device (mfd) systemXEROX CORP·Filed 2024·Application pending·0 cites
- 1247US2025254244A1Multi-function device (mfd) systemXEROX CORP·Filed 2024·Application pending·0 cites
- 1342US2010068142A1Melanoma repopulating cellsGEDYE CRAIG·Filed 2007·Application pending·0 cites
- 1440US2018060938A1Scale-based customer queueing systemILLINOIS TOOL WORKS·Filed 2017·Application pending·0 cites
- 1537US2012171232A1In vivo efficacy of ny-eso-1 plus adjuvantCEBON JONATHAN·Filed 2011·Application pending·0 cites
- 1636US2013123345A1Method of treating a viral infection dysfunction by disrupting an adenosine receptor pathwayDAVIS IAN C·Filed 2011·Application pending·0 cites
- 1735US2016000894A1In vivo efficacy of ny-eso-1 plus adjuvantCSL LTD·Filed 2015·Application pending·0 cites
- 1829US2007219224A1Compositions and Methods Relating to Pyrimidine Synthesis InhibitorsUAB RES FOUNDATION THE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →